Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 7, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2023

Conditions
Ischemic Stroke, Acute
Interventions
DRUG

Sarecycline Tablet

Each tablet contained 100 mg of Sarecycline.

DRUG

Placebo tablets of Sarecycline tablets

Each tablet contained 0 mg of Sarecycline.

Trial Locations (1)

100050

RECRUITING

Beijing Tiantan Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Neurodawn Pharmaceutical Co., Ltd.

INDUSTRY

lead

Beijing Tiantan Hospital

OTHER